Cargando…

Early assessment of response to induction therapy in acute myeloid leukemia using (18)F-FLT PET/CT

BACKGROUND: We evaluated the suitability of (18)F-fluorodeoxythymidine ((18)F-FLT) positron emission tomography (PET)/computed tomography (CT) for assessment of the early response to induction therapy and its value for predicting clinical outcome in patients with acute myeloid leukemia (AML). Adult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Eun Ji, Lee, Bo-hee, Kim, Jeong-A, Park, Young Ha, Choi, Woo Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602811/ https://www.ncbi.nlm.nih.gov/pubmed/28916904 http://dx.doi.org/10.1186/s13550-017-0326-8

Ejemplares similares

(18)F-FLT PET/CT in Patients with Gastric Carcinoma
por: Małkowski, Bogdan, et al.
Publicado: (2013)

A Pilot Study of 18F-FLT PET/CT in Pediatric Lymphoma
por: Costantini, Danny L., et al.
Publicado: (2016)

The usefulness of F-18 FDG PET/CT-mammography for preoperative staging of breast cancer: comparison with conventional PET/CT and MR-mammography
por: Moon, Eun-Ha, et al.
Publicado: (2013)

(18)F-FLT PET/CT imaging in a Wister rabbit inflammation model
por: TAN, YEYING, et al.
Publicado: (2014)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
por: Rendl, Gundula, et al.
Publicado: (2014)

(18)F-FLT and (18)F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
por: Qi, Shi, et al.
Publicado: (2017)

Extramedullary haematopoiesis imaging with (18)F-FLT PET
por: Agool, Ali, et al.
Publicado: (2010)

Differences between [(18)F]FLT and [(18)F]FDG Uptake in PET/CT Imaging in CC Depend on Vaginal Bacteriology
por: Burchardt, Ewa, et al.
Publicado: (2021)

Cell proliferation detected using [(18)F]FLT PET/CT as an early marker of abdominal aortic aneurysm
por: Gandhi, Richa, et al.
Publicado: (2019)

Myeloid Sarcoma of the Prostatic Tissue Diagnosed on 18F-FDG PET/CT in Treated Case of Acute Myeloid Leukemia
por: Gosavi, Atul Yashwant, et al.
Publicado: (2021)

Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era
por: Choi, Sujin, et al.
Publicado: (2020)

Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT in Lung Cancer
por: Kairemo, Kalevi, et al.
Publicado: (2020)

Non-invasive Early Response Monitoring of Nanoparticle-assisted Photothermal Cancer Therapy Using (18)F-FDG, (18)F-FLT, and (18)F-FET PET/CT Imaging
por: Jørgensen, Jesper Tranekjær, et al.
Publicado: (2018)

Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
por: Nikaki, Alexandra, et al.
Publicado: (2019)

Limits of [(18)F]-FLT PET as a Biomarker of Proliferation in Oncology
por: McKinley, Eliot T., et al.
Publicado: (2013)

FLT4 as a marker for predicting prognostic risk of refractory acute myeloid leukemia
por: Lee, Ji Yoon, et al.
Publicado: (2023)

Impact of [(18)F]FDG-PET and [(18)F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer
por: Christensen, Tine N., et al.
Publicado: (2021)

Evaluation of (18)F-fluorothymidine positron emission tomography ([(18)F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer
por: Sharma, R., et al.
Publicado: (2016)

Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study
por: Kairemo, Kalevi, et al.
Publicado: (2020)

Prospective comparison of early interim (18)F-FDG-PET with (18)F-FLT-PET for predicting treatment response and survival in metastatic breast cancer
por: Su, Tzu-Pei, et al.
Publicado: (2021)

The Role of (18)F-FLT PET/CT in Assessing Early Response to Transarterial Radioembolization and Chemoembolization in Patients with Primary and Metastatic Liver Tumors
por: Nak, Demet, et al.
Publicado: (2022)

Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined (18)F-FDG and (18)F-FLT PET/CT imaging
por: Sachpekidis, C., et al.
Publicado: (2018)

Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia
por: Song, Moo-Kon, et al.
Publicado: (2022)

Glucose–Thymidine Ratio as a Metabolism Index Using (18)F-FDG and (18)F-FLT PET Uptake as a Potential Imaging Biomarker for Evaluating Immune Checkpoint Inhibitor Therapy
por: Oh, Sera, et al.
Publicado: (2022)

(18)F-FDG PET/CT predicts acute exacerbation in idiopathic pulmonary fibrosis after thoracic surgery
por: Yoon, Hee-Young, et al.
Publicado: (2021)

The Value of (18)F-FDG PET/CT in Evaluating Disease Severity and Prognosis in Idiopathic Pulmonary Fibrosis Patients
por: Yoon, Hee-Young, et al.
Publicado: (2021)

Low Frequency and Variability of FLT3 Mutations in Korean Patients with Acute Myeloid Leukemia
por: Bang, Soo-Mee, et al.
Publicado: (2008)

An Intra-Individual Comparison of MRI, [(18)F]-FET and [(18)F]-FLT PET in Patients with High-Grade Gliomas
por: Nowosielski, Martha, et al.
Publicado: (2014)

Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
por: Lee, Hyo Jeong, et al.
Publicado: (2017)

FLT PET-CT in evaluation of treatment response
por: Sanghera, Bal, et al.
Publicado: (2014)

Early Monitoring Antiangiogenesis Treatment Response of Sunitinib in U87MG Tumor Xenograft by (18)F-FLT MicroPET/CT Imaging
por: Bao, Xiao, et al.
Publicado: (2014)

Prognostic Value of Baseline (18)F-Fluorodeoxyglucose PET/CT in Patients with Multiple Myeloma: A Multicenter Cohort Study
por: Moon, Seung Hwan, et al.
Publicado: (2018)

FLT3 inhibitors in acute myeloid leukemia
por: Wu, Mei, et al.
Publicado: (2018)

(18)F-FLT PET/MRI for bone marrow failure syndrome-initial experience
por: Tsujikawa, Tetsuya, et al.
Publicado: (2019)

(18)F-FDG PET/CT in Primary AL Hepatic Amyloidosis Associated with Multiple Myeloma
por: Son, Youn Mi, et al.
Publicado: (2011)

Early Assessment of the Efficacy of Temozolomide Chemotherapy in Experimental Glioblastoma Using [(18)F]FLT-PET Imaging
por: Viel, Thomas, et al.
Publicado: (2013)

Primary Benign Intraosseous Meningioma on (18)F-FDG PET/CT Mimicking Malignancy
por: Kim, Ho Seong, et al.
Publicado: (2014)

Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in FLT3-mutated acute myeloid leukemia
por: Lee, Julia S., et al.
Publicado: (2023)

Correction: Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
por: Lee, Hyo Jeong, et al.
Publicado: (2018)

High Transcript Level of FLT3 Associated with High Risk of Relapse in Pediatric Acute Myeloid Leukemia
por: Kang, Hyoung Jin, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2anc356upv4pkr56acuhs0l8fi